Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease

被引:48
|
作者
Arai, Takeo
Fukae, Jiro
Hatano, Taku
Kubo, Shin-ichiro
Ohtsubo, Toshio
Nakabeppu, Yusaku
Mori, Hideo
Mizuno, Yoshikuni
Hattori, Nobutaka
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka 8128582, Japan
关键词
Parkinson's disease; oxidative stress; hMUTYH; DNA repair enzyme;
D O I
10.1007/s00401-006-0081-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is ample evidence for the involvement of oxidative stress in mitochondrial DNA damage and repair mechanisms in Parkinson's disease (PD). The human MutY homolog (hMUTYH) which removes misincorporated adenine opposite 8-oxoG in DNA functions in post-replication, and is localized in the nuclei and mitochondria. We hypothesized that hMUTYH is involved in the disease process of PD. To test our hypothesis, we performed immunohistochemical and biochemical studies on brains of patients with PD and those of control patients. Our results showed up-regulation of hMUTYH in the mitochondria of the SN of PD patients. Western blot analysis also revealed high hMUTYH levels in PD patients and expression of a 47-kDa molecule in the brains as the major isoform. This molecule was localized within the mitochondria as confirmed by double staining with a mitochondrial marker. To confirm the presence of this molecule, we examined the mRNAs of isoforms that translate to the 47-kDa molecule. Based on the amount of mRNAs, the major molecule was alpha 4. Interestingly, this molecule lacks the mitochondria targeting sequence. Our results suggest that hMUTYH might be a useful marker of oxidative stress and that oxidative stress and genomic instability are important in the PD disease process.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [41] MiRNA Profile in the Substantia Nigra of Parkinson's Disease and Healthy Subjects
    Cardo, Lucia F.
    Coto, Eliecer
    Ribacoba, Rene
    Menendez, Manuel
    Moris, German
    Suarez, Esther
    Alvarez, Victoria
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 54 (04) : 830 - 836
  • [42] α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
    Vila, M
    Vukosavic, S
    Jackson-Lewis, V
    Neystat, M
    Jakowec, M
    Przedborski, S
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) : 721 - 729
  • [43] Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
    Miller, RM
    Kiser, GL
    Kaysser-Kranich, TM
    Lockner, RJ
    Palaniappan, C
    Federoff, HJ
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 305 - 313
  • [44] Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease
    Seyfried, T. N.
    Choi, H.
    Chevalier, A.
    Hogan, D.
    Akgoc, Z.
    Schneider, J. S.
    ASN NEURO, 2018, 10
  • [45] Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease
    Jesus-Ribeiro, Joana
    Sargento-Freitas, Joao
    Sousa, Mario
    Silva, Fernando
    Freire, Antonio
    Januario, Cristina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 364 : 9 - 11
  • [46] Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
    Liu, Wenyue
    Wang, Changpeng
    He, Tingting
    Su, Minghong
    Lu, Yuan
    Zhang, Guanyu
    Munte, Thomas F.
    Jin, Lirong
    Ye, Zheng
    JOURNAL OF NEUROSCIENCE, 2021, 41 (29): : 6304 - 6313
  • [47] Abnormal DNA Methylation in Substantia Nigra Region of MPTP-induced Mouse Model of Parkinson's Disease
    Hu Ya-Cen
    Xu Qian
    Guo Ji-Feng
    Ai San-Xi
    Song Cheng-Yuan
    Sun Qi-Ying
    Weng Ling
    Zhou Lin
    Jiang Hong
    Shen Lu
    Yan Xin-Xiang
    Tang Bei-Sha
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (03) : 277 - 285
  • [48] Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease
    Knott, C
    Wilkin, GP
    Stern, G
    PARKINSONISM & RELATED DISORDERS, 1999, 5 (03) : 115 - 122
  • [49] Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease
    Schweitzer, KJ
    Hilker, R
    Walter, U
    Burghaus, L
    Berg, D
    MOVEMENT DISORDERS, 2006, 21 (01) : 94 - 98
  • [50] Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
    Carmona, Asuncion
    Carboni, Eleonora
    Gomes, Lucas Caldi
    Roudeau, Stephane
    Maass, Fabian
    Lenz, Christof
    Ortega, Richard
    Lingor, Paul
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (02) : 128 - 141